HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 50.20
Day range
kr 49.45 - kr 51.80
Year range
kr 30.90 - kr 91.70
Market cap
1.28B SEK
Avg Volume
20.52K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 53.81M | 6.33% |
Net income | -53.58M | -4.24% |
Net profit margin | — | — |
Earnings per share | -1.64 | — |
EBITDA | -51.46M | -6.38% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.57M | 301.27% |
Total assets | 736.07M | 31.18% |
Total liabilities | 67.93M | -25.40% |
Total equity | 668.14M | — |
Shares outstanding | 33.76M | — |
Price to book | 2.54 | — |
Return on assets | -18.66% | — |
Return on capital | -19.73% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -53.58M | -4.24% |
Cash from operations | -64.18M | -13.59% |
Cash from investing | -8.74M | 45.48% |
Cash from financing | 95.32M | 113.36% |
Net change in cash | 22.42M | 180.49% |
Free cash flow | -52.29M | -686.92% |
About
Founded
2003
Website
Employees
26
